Cyclacel Pharmaceuticals, Inc. (CYCC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.27M |
| Enterprise value | -71.72k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.02 |
| Price/book (mrq) | 5.39 |
| Enterprise value/revenue | -0.17 |
| Enterprise value/EBITDA | 0.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.57 |
| 52-week change 3 | -66.03% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 13.2000 |
| 52-week low 3 | 1.3000 |
| 50-day moving average 3 | 2.2222 |
| 200-day moving average 3 | 4.7129 |
Share statistics
| Avg vol (3-month) 3 | 768.68k |
| Avg vol (10-day) 3 | 4.47M |
| Shares outstanding 5 | 1.32M |
| Implied shares outstanding 6 | 1.32M |
| Float 8 | 1.14M |
| % held by insiders 1 | 7.12% |
| % held by institutions 1 | 16.73% |
| Shares short (15 Apr 2024) 4 | 38.41k |
| Short ratio (15 Apr 2024) 4 | 1.21 |
| Short % of float (15 Apr 2024) 4 | 3.08% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.91% |
| Shares short (prior month 15 Mar 2024) 4 | 26.61k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 15 Apr 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 18 Dec 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -17,290.32% |
Management effectiveness
| Return on assets (ttm) | -86.33% |
| Return on equity (ttm) | -272.63% |
Income statement
| Revenue (ttm) | 420k |
| Revenue per share (ttm) | 0.49 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -25.42M |
| Net income avi to common (ttm) | -22.76M |
| Diluted EPS (ttm) | -26.7500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.38M |
| Total cash per share (mrq) | 2.56 |
| Total debt (mrq) | 37k |
| Total debt/equity (mrq) | 6.10% |
| Current ratio (mrq) | 0.91 |
| Book value per share (mrq) | 0.57 |
Cash flow statement
| Operating cash flow (ttm) | -16.11M |
| Levered free cash flow (ttm) | -11.76M |
© 2024 Yahoo. All rights reserved.